Marco Banini
Overview
Explore the profile of Marco Banini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gelmini S, Calabri A, Mancini I, Comin C, Pasini V, Banini M, et al.
Int J Mol Sci
. 2025 Jan;
26(2.
PMID: 39859325
The expression level of Programmed Death-Ligand 1 (PD-L1) determined by the immunohistochemical method is currently approved to test the potential efficacy of immune-checkpoint inhibitors and to candidate patients with Non-Small...
2.
Salvestrini V, Lastrucci A, Banini M, Loi M, Carnevale M, Olmetto E, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766035
Stereotactic body radiotherapy has been established as a viable treatment option for inoperable early-stage non-small cell lung cancer or secondary lesions mainly in oligoprogressive/oligometastatic scenarios. Treating lesions in the so-called...
3.
Desideri I, Morelli I, Banini M, Greto D, Visani L, Nozzoli F, et al.
Radiother Oncol
. 2024 Jun;
197:110378.
PMID: 38857703
No abstract available.
4.
Desideri I, Morelli I, Banini M, Greto D, Visani L, Nozzoli F, et al.
Radiother Oncol
. 2024 Apr;
195:110271.
PMID: 38588920
Purpose: Re-irradiation (re-RT) for recurrent intracranial meningiomas is hindered by the limited radiation tolerance of surrounding tissue and the risk of side effects. This study aimed at assessing outcomes, toxicities...
5.
Francolini G, Allegra A, Detti B, Di Cataldo V, Caini S, Bruni A, et al.
J Clin Oncol
. 2023 Sep;
41(36):5561-5568.
PMID: 37733977
Purpose: ARTO (ClinicalTrials.gov identifier: NCT03449719) is a multicenter, phase II randomized clinical trial testing the benefit of adding stereotactic body radiation therapy (SBRT) to abiraterone acetate and prednisone (AAP) in...
6.
Banini M, Visani L, Livi L, Meattini I
Ann Transl Med
. 2023 Sep;
11(10):366.
PMID: 37675297
No abstract available.
7.
Banini M, Salvestrini V, Vultaggio A, Perlato M, Mecheri V, Cerbai C, et al.
Curr Oncol
. 2023 Jul;
30(7):6699-6707.
PMID: 37504351
Background: The landscape of systemic therapies for advanced non-melanoma skin cancers has been revolutionized by the advent of immunotherapy. Cemiplimab is the only immune checkpoint inhibitor (ICI) approved by the...
8.
Francolini G, Banini M, Di Cataldo V, Detti B, Caini S, Loi M, et al.
Prostate
. 2023 Jun;
83(12):1201-1206.
PMID: 37290915
Background: Ultrasensitive imaging has been demonstrated to influence biochemical relapse treatment. PSICHE is a multicentric prospective study, aimed at exploring detection rate with 68Ga-PSMA-11 positron emission tomography/computed tomography (PET/CT) and...
9.
Franco P, De Felice F, Kaidar-Person O, Gabrys D, Marta G, Banini M, et al.
Int J Radiat Oncol Biol Phys
. 2023 Feb;
116(2):232-245.
PMID: 36841344
The promotion of equity, diversity, and inclusion (EDI) is being increasingly pursued in health care, both in general and within radiation oncology. Because bibliometrics is a powerful tool to reveal...
10.
Francolini G, Frosini G, Di Cataldo V, Detti B, Carnevale M, Banini M, et al.
J Geriatr Oncol
. 2022 Dec;
14(1):101411.
PMID: 36496347
Introduction: Taxane-based chemotherapy is one of the main cornerstones for treatment of metastatic prostate cancer (mPCa). In aged and well-fit patients, an indication for taxane chemotherapy should remain similar to...